Alleviation of the liver injuries in mice after treatment with C3aR antagonist. by Shihui Sun (180042)

“…(G–H) <i>C3aR</i> mRNA expression decreased at 8 hours compared with that of the saline group, whereas <i>C5aR</i> mRNA expression decreased from 4 to 8 hours (n = 4–5). …”

Discovery of <i>N</i>‑[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl... by John S. Debenham (2295976)

“…Mouse and rat studies showed hematological changes with elevations of plasma EPO and circulating reticulocytes following single oral dose administration, while 4-week q.d. po administration in rat elevated hemoglobin levels. A major focus of the optimization process was to decrease the long half-life observed in higher species with early compounds. …”

Annual average incidence rates of human rabies in provinces from 2004–2020. by Weiwei Meng (304234)

Table_1_BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists.docx by Andrés Noé (3620534)

“…Samples from 29 children, aged 5-11 years, before and 28 days after a second BNT162b2 vaccination were analysed (V2 + 28). …”

DataSheet_1_BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists.zip by Andrés Noé (3620534)

“…Samples from 29 children, aged 5-11 years, before and 28 days after a second BNT162b2 vaccination were analysed (V2 + 28). …”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…Background<p>To investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test.…”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…Background<p>To investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test.…”

Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx by Tatsuhiko Wada (14391781)

“…Background<p>To investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test.…”

Identification of phospholipids categories in SVA 3C^pro. by Hai-Fan Zhao (15990862)

Table_1_BNP as a New Biomarker of Cardiac Thyroid Hormone Function.DOCX by Kaihao Wang (9100646)

“…Myocardial BNP mRNA was increased 2.5-fold in Hypo rats and its expression was decreased to normal values by 14 days of T3 treatment. …”

Interaction of meropenem with ‘N’ and ‘B’ isoforms of human serum albumin: a spectroscopic and molecular docking study by Md. Tabish Rehman (355007)

“…Here, we investigated the interaction between meropenem and HSA at physiological pH 7.5 (N-isoform HSA) and non-physiological pH 9.2 (B-isoform HSA). …”

Exhaled metabolic markers and relevant dysregulated pathways of lung cancer: a pilot study by Yingchang Zou (12217753)

<i>RR</i> of the spatio-temporal interaction effect for Human Rabies in China from 2004–2020. by Weiwei Meng (304234)

<i>RR</i> of the spatial effect and distribution of hot-cold spots. by Weiwei Meng (304234)

Fat mass loss survival curve by sex during inpatient treatment. by Domingos L. S. Rios (20496173)

Influence of Solubilizing Group Removal Rate on the Morphology and Crystallinity of a Diketopyrrolopyrrole-Based Compound by Shabi Thankaraj Salammal (1864396)

“…The X-ray and atomic force microscopic investigations of “3,6-di­(2,2′-bithio­phen-5-yl)­pyrrolo­[3,4-<i>c</i>]­pyrrole-1,4-(2<i>H</i>,5<i>H</i>)-dione” (DPP-4T) synthesized from its precursor (di-<i>tert</i>-butyl-3,6-di­(2,2′-bithio­phen-5-yl)-1,4-dioxo­pyrrolo­[3,4-<i>c</i>]­pyrrole-2,5-(1<i>H</i>,4<i>H</i>)-dicarboxylate) through thermal conversion reveals that the solubilizing group removal rate plays a crucial role on the ultimate grain size and crystallinity of the final compound (DPP-4T). …”

Influence of Solubilizing Group Removal Rate on the Morphology and Crystallinity of a Diketopyrrolopyrrole-Based Compound by Shabi Thankaraj Salammal (1864396)

“…The X-ray and atomic force microscopic investigations of “3,6-di­(2,2′-bithio­phen-5-yl)­pyrrolo­[3,4-<i>c</i>]­pyrrole-1,4-(2<i>H</i>,5<i>H</i>)-dione” (DPP-4T) synthesized from its precursor (di-<i>tert</i>-butyl-3,6-di­(2,2′-bithio­phen-5-yl)-1,4-dioxo­pyrrolo­[3,4-<i>c</i>]­pyrrole-2,5-(1<i>H</i>,4<i>H</i>)-dicarboxylate) through thermal conversion reveals that the solubilizing group removal rate plays a crucial role on the ultimate grain size and crystallinity of the final compound (DPP-4T). …”

Nutritional profile of patients in a multidisciplinary treatment program for severe obesity and preoperative bariatric surgery by Fernanda Cristina Carvalho Mattos MAGNO (6380201)

“…It was observed that in the 5th appointment more than 50% of the patients underwent six meals a day. …”

Background compensation by coherent feedback in the scheme of Fig 13. by Melissa Nygård (15374507)

Blindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye Clinics by Luca Rossetti (711357)

“…During follow-up the IOP decreased by 14% in these eyes but MD deteriorated by 1.1±3.5 dB/year, which was 5-fold higher than controls (0.2±1.6 dB/year). …”